Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
In the randomized, double-blind, clinical phase III trial NCT01853124, it was discovered that administering Lacticaseibacillus rhamnosus + Lactobacillus delbrueckii bulgaricus twice daily to children with gastroenteritis did not prevent the occurrence of moderate-to-severe gastroenteritis within 14 days following enrollment.
see also:
Diarrhea / Diarrhoea in children & Drugs/Treatments
[Lactobacillus](brain://W104JYs6bkaILO…